Table 2 Summary of therapeutic and survival data in patients who received curative resection.
From: Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study
| Â | Mucosal melanoma (n = 87), N (%) | Ocular melanoma N (%) | ||||||
|---|---|---|---|---|---|---|---|---|
| Â | Total | Anorectum | Genitourinary | Gastrointestinal | Nasal | Oral | Maxillary sinus | Â |
No. | 87 | 31 | 17 | 1 | 23 | 11 | 4 | 13 |
   R1 resection | 25 | 2(6.5) | 5(29.4) | 0 | 12(52.2) | 5(45.5) | 1(25.0) | 5(38.5) |
   R0 resection | 62 | 29(93.5) | 12(70.6) | 1(100) | 11(47.8) | 6(54.5) | 3(75.0) | 8(61.5) |
Adjuvant treatment | Â | Â | Â | Â | Â | Â | Â | Â |
   No | 53 | 20(64.5) | 8(47.1) | 1(100) | 18(78.3) | 4(36.4) | 2(50.0) | 7(53.8) |
   Chemotherapy | 22 | 10(32.3) | 6(35.3) | 0 | 0(0.0) | 4(36.4) | 0 | 2(15.4) |
IFN | 14 | 5 | 4 | 0 | 0(0.0) | 3 | 0 | 2 |
Cytotoxic | 8 | 5 | 2 | 0 | 0(0.0) | 1 | 0 | 0 |
   Radiotherapy only | 14 | 1(3.2) | 3(17.6) | 0 | 5(21.7) | 3(27.2) | 2(50.0) | 4(30.8) |
Relapse after resection | Â | Â | Â | Â | Â | Â | Â | Â |
   None | 36 | 11(35.5) | 7(41.2) | 0 | 12(52.2) | 5(45.4) | 1(25.0) | 6(46.2) |
   Local relapse | 21 | 7(22.6) | 1(5.9) | 0 | 8(34.8) | 4(36.4) | 1(25.0) | 4(30.8) |
   Systemic | 30 | 13(41.9) | 9(52.9) | 1(100) | 3(13.0) | 2(18.2) | 2(50.0) | 3(23.0) |
Palliative treatment after recurrence (total n = 51) | Â | Â | Â | Â | Â | Â | Â | Â |
   Chemotherapy only | 9 (17.6) | 3 | 2 | 0 | 3 | 1 | 0 | 3(42.9) |
   Radiotherapy only | 10 (19.6) | 3 | 2 | 0 | 2 | 3 | 0 | 1(14.3) |
   Resection | 6 (11.7) | 2 | 1 | 1 | 0 | 1 | 1 | 0 |
Current status | Â | Â | Â | Â | Â | Â | Â | Â |
   No evidence of disease | 31 (35.6) | 12(38.7) | 7(41.2) | 0 | 7(30.4) | 5(45.5) | 0(0.0) | 5(38.5) |
   Alive with disease | 6 (6.9) | 1(3.2) | 1(5.9) | 0 | 2(8.7) | 1(9.0) | 1(25.0) | 2(15.3) |
   Dead of disease | 50 (57.5) | 18(58.1) | 9(52.9) | 1(100) | 14(60.9) | 5(45.5) | 3(75.0) | 6(46.2) |
Overall Survival (%) | Â | Â | Â | Â | Â | Â | Â | Â |
   2 years | 59.7 | 61.3 | 68.4 | - | 46.9 | 53.0 | 75.0 | 73.3 |
   5 years | 31.9 | 30.6 | 39.1 | - | 25.1 | 39.8 | - | - |
Median survival months (95% CI) | 34.6 (24.5-44.7) | 28.6 (18.2-38.9) | 43.9 (29.6-58.2) | 7.5 (NA) | 23.4 (7.4-8.9) | 38.9 (13.4-64.4) | 24.4 (0-49.3) | 51.2 (NA) |